US FDA plans external expert network for emerging technologies
This article was originally published in Clinica
The US Food and Drug Administration has set in motion plans to create a network of external scientific experts that its devices unit can use to gain faster access to specialised knowledge about emerging technologies and other topics.
You may also be interested in...
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.
The World Health Organization has proposed changes to its 2016 guideline on data integrity requirements to provide streamlined information to sponsors and to take account of experience gained to date.
EU regulators say that sponsors must complete their nitrosamine-related risk evaluations for all EU medicines containing chemically-synthesised active substances within the six-month timeframe.